Author Correction:Discovery of toxoflavin,a potent IRE1αinhibitor acting through structure-dependent oxidative inhibition  

作　　者：Kai-long Jiang Chang-mei Liu Li-tong Nie Hai-ni Jiang Lei Xu Kun-zhi Zhang Li-xia Fan An-hui Gao Lu-lin Lin Xiang-yu Wang Min-jia Tan Qi-qing Zhang Yu-bo Zhou Jia Li 

机构地区：[1]Institute of Biomedical Engineering,The Second Clinical Medical College,Jinan University(Shenzhen People’s Hospital),Shenzhen 518020,China [2]Zhongshan Institute for Drug Discovery,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Zhongshan 528400,China [3]State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China [4]University of Chinese Academy of Sciences,Beijing 100049,China [5]The First Affiliated Hospital,Jinan University,Guangzhou 510632,China [6]School of Pharmaceutical Science,Jiangnan University,Wuxi 214122,China [7]School of Pharmacy,Zunyi Medical University,Zunyi 563006,China [8]Zhejiang Center for Medical Device Evaluation,Zhejiang Medical Products Administration,Hangzhou 311121,China [9]Shanghai Tech University,Shanghai 201210,China

出　　处：《Acta Pharmacologica Sinica》2023年第12期2550-2550,共1页中国药理学报（英文版）

摘　　要：The authors are very sorry for two mistakes in the spelling of two authors’names among the listed co-authors:The 9th author“Luling Lin”and 11th author“Ming-jia Tan”were spelled incorrectly,and the correct spelling should be“Lu-lin Lin”and“Min-jia Tan”.These errors were made completely by accident,due to our negligence.The authors apologize for any inconvenience caused to the Journal and readers.

关 键 词：LISTED MISTAKE accident 

分 类 号：R737.14[医药卫生—肿瘤]